Method for producing pyripyropene derivative by enzymatic process

Details for Australian Patent Application No. 2011210969 (hide)

Owner Meiji Seika Pharma Co., Ltd.

Inventors Yamamoto, Kentaro; Tsuchida, Mariko; Oyama, Kazuhiko; Goto, Kimihiko; Mitomi, Masaaki

Agent Davies Collison Cave

Pub. Number AU-A-2011210969

PCT Pub. Number WO2011/093187

Priority 2010-014336 26.01.10 JP; 2010-014727 26.01.10 JP

Filing date 19 January 2011

Wipo publication date 4 August 2011

International Classifications

C12P 17/18 Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

C07D 493/04 Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/093187 Priority application(s): WO2011/093187

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011211009-Low-temperature tank

2011210968-Nucleic acid structure containing a pyripyropene biosynthesis gene cluster and a marker gene